SS
RMD icon

SBI Securities’s ResMed RMD Stock Holding History

SBI Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
205
+8
+4% +$1.66K ﹤0.01% 1255
2026
Q1 		$44.2K Buy
197
+123
+166% +$30.7K ﹤0.01% 1149
2025
Q4 		$17.8K Sell
74
-8
-10% -$2.05K ﹤0.01% 1486
2025
Q3 		$22.4K Sell
82
-8
-9% -$2.19K ﹤0.01% 1402
2025
Q2 		$23.2K Sell
90
-32
-26% -$7.63K ﹤0.01% 1360
2025
Q1 		$27.3K Sell
122
-171
-58% -$39.9K ﹤0.01% 1214
2024
Q4 		$67K Buy
+293
New +$70.5K ﹤0.01% 887

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SBI Securities's RMD Position: Q2 2026 in Review

SBI Securities increased its ResMed (RMD) stake by 4.1% in Q2 2026, buying an estimated $1.66K and bringing the position to 205 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

SBI Securities first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $67K in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SBI Securities held 205 shares of ResMed worth $40K as of Q2 2026.
  • SBI Securities bought 8 ResMed shares in Q2 2026, an estimated $1.66K.
  • ResMed made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1255 holding.
  • SBI Securities first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's ResMed position peaked at $67K in Q4 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.